Simcere Pharmaceutical announced that Sanbexin® sublingual tablets (generic name: edaravone and dexborneol sublingual tablets ...

Acute kidney injury (AKI) often occurs as a result of ischemia, which is a condition in which blood flow to part of the body ...

Learn about atorvastatin-loaded PEGylated liposomes as a targeted therapeutic approach for treating ischemic stroke, focusing ...

MINNEAPOLIS, December 03, 2024--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic ...

Mesoblast Limited (AU:MSB) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with TipRanks Premium - ...

Acute kidney injury (AKI) often occurs as a result of ischemia, which is a condition in which blood flow to part of the body ...

Hepatic ischemia-reperfusion injury (HIRI) is a key factor leading to complications and poor prognosis after hepatobiliary surgery, but its pathogenesis remains unclear. Hence, it is a very necessary ...

Factors portending the greatest risk for cardiovascular death in control patients were inflammation (baseline plasma high-sensitivity C-reactive protein =2 mg/L; p=0.003) and ischemic HFrEF etiology ...

Although scientists estimate that more than 230 million people worldwide suffer from Peripheral Artery Disease, it is often ...

Simcere Pharmaceutical Group Limited (HK:2096) has released an update. Simcere Pharmaceutical Group Limited has received approval from China’s ...

It has now been 25 years since prourokinase was in the spotlight as a potential treatment for acute ischaemic stroke. In 1999, the PROACT-II randomised controlled trial compared intra-arterial ...

New study finds using oral combined continuous therapy was associated with increased risk of ischemic heart disease ...